AMERICAN BIOMED, Minimally Invasive Technology (ABMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ray Tarke who wrote (906)	5/25/1998 10:29:00 PM
From: Jeffrey L. Henken	Read Replies (2) of 2887

A couple of months ago I pasted some of American BioMed's projections for 1998 here on this thread: Message 3796845 1998 THE YEAR OF ABMI: Cathlab Division Profitable Strategic Partner Selected Stent Clinical Trials to Commence FDA Approval for OmniCath AV Fistula Clinical Trials to Begin FDA Approval to Sell New Thrombectomy and Infusion Catheters Record Revenue Performance SO HOW IS THE COMPANY DOING? Well the Cathlab profits are increasing but we need to see CE Mark approval in order to assure sales growing. Will it happen soon? I think so because the only thing stopping approval is the bureaucratic nightmare surrounding this process. Certainly American BioMed has all it's ducks in a row or we would not even have ISO 9001 certification. No strategic partner yet, but since when are we supposed to know about those agreements before they are announced. Do I think we will finally see a strategic partner announced this year? You bet I do! Stents trials begin in 1998? Why not after all we have a $5 million equity line of credit. Not only that but it's possible that a strategic partner might be involved in our stent trials. biz.yahoo.com americanbiomed.com The FDA approval of the AV Fistula trials for the OmniCath? People this could happen any day and actual FDA approval for this huge market could come as little as 12 months after the trials begin. Message 4570080 FDA Approval to Sell New Thrombectomy and Infusion Catheters? The Ahn Thrombectomy Catheter could start actual sales any day now. The FDA approval of it's four additional infusion catheters could also come any day. americanbiomed.com Record Revenue Performance? I think the first quarter numbers speak for themselves. American BioMed is already on it's way! biz.yahoo.com GO ABMI! Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next